 Michael Kahn
Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 21 | 2021 | 830 | 3.020 |
Why?
| | Medical Informatics | 6 | 2017 | 102 | 1.850 |
Why?
| | Data Accuracy | 6 | 2022 | 57 | 1.720 |
Why?
| | Biomedical Research | 9 | 2018 | 612 | 1.540 |
Why?
| | Pediatrics | 5 | 2019 | 985 | 1.360 |
Why?
| | Medical Record Linkage | 8 | 2020 | 53 | 1.320 |
Why?
| | Crowding | 3 | 2011 | 38 | 1.190 |
Why?
| | Health Services Research | 3 | 2019 | 385 | 1.020 |
Why?
| | Computer Communication Networks | 2 | 2014 | 33 | 0.980 |
Why?
| | Comparative Effectiveness Research | 5 | 2017 | 132 | 0.970 |
Why?
| | Quality of Health Care | 4 | 2013 | 586 | 0.870 |
Why?
| | Data Warehousing | 1 | 2022 | 5 | 0.850 |
Why?
| | Rare Diseases | 1 | 2023 | 113 | 0.850 |
Why?
| | Cloud Computing | 1 | 2022 | 8 | 0.850 |
Why?
| | Machine Learning | 2 | 2023 | 331 | 0.750 |
Why?
| | Patient-Centered Care | 3 | 2014 | 497 | 0.740 |
Why?
| | Information Storage and Retrieval | 5 | 2020 | 124 | 0.720 |
Why?
| | Quality Assurance, Health Care | 3 | 2012 | 325 | 0.670 |
Why?
| | Urology | 1 | 2018 | 48 | 0.610 |
Why?
| | Child Health | 1 | 2019 | 137 | 0.600 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 968 | 0.590 |
Why?
| | Databases, Factual | 6 | 2019 | 1231 | 0.560 |
Why?
| | Medical Records Systems, Computerized | 4 | 2012 | 92 | 0.540 |
Why?
| | Data Mining | 2 | 2017 | 113 | 0.540 |
Why?
| | Child Welfare | 2 | 2014 | 199 | 0.520 |
Why?
| | Terminology as Topic | 2 | 2014 | 211 | 0.490 |
Why?
| | Forms and Records Control | 1 | 2013 | 23 | 0.480 |
Why?
| | Community Networks | 1 | 2014 | 59 | 0.470 |
Why?
| | Quality Improvement | 1 | 2021 | 963 | 0.470 |
Why?
| | Quality Indicators, Health Care | 3 | 2013 | 295 | 0.440 |
Why?
| | Population Surveillance | 3 | 2020 | 413 | 0.430 |
Why?
| | Wearable Electronic Devices | 2 | 2021 | 34 | 0.390 |
Why?
| | Humans | 54 | 2024 | 119032 | 0.390 |
Why?
| | Nursing Assessment | 1 | 2011 | 46 | 0.390 |
Why?
| | Analgesia | 1 | 2011 | 81 | 0.380 |
Why?
| | Emergency Service, Hospital | 2 | 2011 | 1864 | 0.370 |
Why?
| | Child | 17 | 2020 | 19137 | 0.360 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2010 | 69 | 0.360 |
Why?
| | Models, Statistical | 2 | 2019 | 636 | 0.350 |
Why?
| | Decision Support Systems, Clinical | 2 | 2023 | 178 | 0.350 |
Why?
| | Mass Screening | 2 | 2020 | 1052 | 0.350 |
Why?
| | Information Dissemination | 3 | 2019 | 210 | 0.350 |
Why?
| | United States | 18 | 2022 | 12557 | 0.340 |
Why?
| | Pain | 2 | 2011 | 736 | 0.340 |
Why?
| | Heart Defects, Congenital | 3 | 2020 | 703 | 0.340 |
Why?
| | Accidental Falls | 1 | 2011 | 154 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2020 | 2179 | 0.300 |
Why?
| | Organizational Policy | 1 | 2007 | 70 | 0.300 |
Why?
| | beta Catenin | 2 | 2023 | 219 | 0.290 |
Why?
| | Pregnenes | 1 | 2006 | 1 | 0.290 |
Why?
| | Fluorine | 1 | 2006 | 15 | 0.280 |
Why?
| | Adolescent | 16 | 2022 | 18483 | 0.260 |
Why?
| | Receptors, Glucocorticoid | 1 | 2006 | 133 | 0.260 |
Why?
| | Child, Preschool | 9 | 2020 | 9493 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2020 | 3361 | 0.250 |
Why?
| | Emergency Medical Services | 1 | 2011 | 589 | 0.250 |
Why?
| | Pyrazoles | 1 | 2006 | 363 | 0.220 |
Why?
| | Pyridines | 1 | 2006 | 440 | 0.220 |
Why?
| | Adrenal Cortex Hormones | 1 | 2006 | 521 | 0.210 |
Why?
| | Infant | 7 | 2020 | 8295 | 0.210 |
Why?
| | Precision Medicine | 2 | 2024 | 363 | 0.210 |
Why?
| | Data Collection | 3 | 2014 | 658 | 0.210 |
Why?
| | Life Cycle Stages | 1 | 2021 | 30 | 0.200 |
Why?
| | Time Factors | 4 | 2014 | 6414 | 0.200 |
Why?
| | Asthma | 2 | 2011 | 2159 | 0.190 |
Why?
| | Education, Distance | 1 | 2021 | 36 | 0.190 |
Why?
| | Young Adult | 8 | 2020 | 10799 | 0.190 |
Why?
| | India | 4 | 2020 | 141 | 0.180 |
Why?
| | Information Services | 1 | 2019 | 46 | 0.170 |
Why?
| | Information Management | 2 | 2012 | 16 | 0.170 |
Why?
| | Sentinel Surveillance | 2 | 2018 | 39 | 0.170 |
Why?
| | Penicillin Resistance | 1 | 1998 | 8 | 0.170 |
Why?
| | Acute Disease | 2 | 2011 | 941 | 0.170 |
Why?
| | Reproducibility of Results | 4 | 2021 | 2874 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2020 | 5256 | 0.160 |
Why?
| | Research Design | 4 | 2021 | 969 | 0.150 |
Why?
| | Male | 15 | 2020 | 57818 | 0.150 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 168 | 0.150 |
Why?
| | Pneumococcal Infections | 1 | 1998 | 96 | 0.150 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2017 | 49 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2017 | 104 | 0.150 |
Why?
| | Colorado | 7 | 2024 | 4196 | 0.150 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2017 | 115 | 0.150 |
Why?
| | Female | 15 | 2020 | 61588 | 0.150 |
Why?
| | Cross-Sectional Studies | 3 | 2011 | 4552 | 0.140 |
Why?
| | Cross Infection | 1 | 1998 | 205 | 0.140 |
Why?
| | Fractures, Bone | 2 | 2011 | 380 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 709 | 0.140 |
Why?
| | Hospitals, University | 2 | 2011 | 172 | 0.140 |
Why?
| | Adult | 9 | 2022 | 31525 | 0.140 |
Why?
| | Logistic Models | 2 | 2011 | 1901 | 0.140 |
Why?
| | Vocabulary, Controlled | 2 | 2014 | 50 | 0.130 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2015 | 64 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 3004 | 0.130 |
Why?
| | Algorithms | 3 | 2020 | 1543 | 0.130 |
Why?
| | Program Development | 2 | 2019 | 357 | 0.120 |
Why?
| | Hydronephrosis | 1 | 2014 | 30 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 505 | 0.120 |
Why?
| | Database Management Systems | 2 | 2012 | 56 | 0.120 |
Why?
| | Chronic Disease | 1 | 2019 | 1637 | 0.110 |
Why?
| | Organizational Innovation | 1 | 2014 | 138 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 37 | 0.110 |
Why?
| | Patient Handoff | 1 | 2013 | 27 | 0.110 |
Why?
| | Interinstitutional Relations | 1 | 2013 | 55 | 0.110 |
Why?
| | Odds Ratio | 2 | 2011 | 996 | 0.110 |
Why?
| | Patient Identification Systems | 1 | 2013 | 19 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 246 | 0.110 |
Why?
| | Multicenter Studies as Topic | 1 | 2013 | 253 | 0.110 |
Why?
| | Models, Theoretical | 2 | 2017 | 556 | 0.110 |
Why?
| | Postoperative Period | 1 | 2013 | 309 | 0.110 |
Why?
| | Operating Rooms | 1 | 2013 | 90 | 0.110 |
Why?
| | Ethics Committees, Research | 1 | 2012 | 44 | 0.100 |
Why?
| | Registries | 4 | 2020 | 1810 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 945 | 0.100 |
Why?
| | Risk Assessment | 2 | 2011 | 3057 | 0.100 |
Why?
| | Documentation | 1 | 2013 | 175 | 0.100 |
Why?
| | Bed Occupancy | 1 | 2011 | 11 | 0.100 |
Why?
| | Narcotics | 1 | 2011 | 50 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2011 | 324 | 0.100 |
Why?
| | Research | 1 | 2014 | 411 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 164 | 0.100 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2012 | 157 | 0.100 |
Why?
| | Heart Failure | 1 | 2023 | 1968 | 0.090 |
Why?
| | Joint Commission on Accreditation of Healthcare Organizations | 1 | 2010 | 7 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2014 | 482 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 176 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 226 | 0.090 |
Why?
| | Analgesics | 1 | 2011 | 159 | 0.090 |
Why?
| | Child, Hospitalized | 1 | 2010 | 43 | 0.090 |
Why?
| | Needs Assessment | 1 | 2011 | 327 | 0.090 |
Why?
| | Patient Safety | 1 | 2013 | 281 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2012 | 408 | 0.090 |
Why?
| | Injury Severity Score | 1 | 2011 | 528 | 0.090 |
Why?
| | Pain Measurement | 1 | 2011 | 469 | 0.090 |
Why?
| | Overweight | 1 | 2013 | 502 | 0.090 |
Why?
| | Pulmonary Fibrosis | 1 | 2012 | 303 | 0.080 |
Why?
| | Pilot Projects | 1 | 2013 | 1420 | 0.080 |
Why?
| | Intensive Care Units | 1 | 2013 | 635 | 0.080 |
Why?
| | Radiography | 1 | 2011 | 861 | 0.080 |
Why?
| | Workflow | 1 | 2010 | 148 | 0.080 |
Why?
| | Pain Management | 1 | 2011 | 293 | 0.080 |
Why?
| | Age of Onset | 2 | 2020 | 467 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2011 | 12990 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2011 | 343 | 0.080 |
Why?
| | Patient Care Team | 1 | 2012 | 522 | 0.080 |
Why?
| | Inpatients | 1 | 2011 | 389 | 0.080 |
Why?
| | Internet | 1 | 2012 | 633 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1474 | 0.070 |
Why?
| | Pediatric Obesity | 1 | 2013 | 524 | 0.070 |
Why?
| | Stereoisomerism | 1 | 2006 | 93 | 0.070 |
Why?
| | Microwaves | 1 | 2006 | 36 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2012 | 963 | 0.070 |
Why?
| | Ambulatory Care Information Systems | 1 | 2005 | 5 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2006 | 522 | 0.060 |
Why?
| | Molecular Structure | 1 | 2006 | 459 | 0.060 |
Why?
| | Aqueous Humor | 2 | 1983 | 31 | 0.060 |
Why?
| | Patient Readmission | 1 | 2010 | 633 | 0.060 |
Why?
| | Positron-Emission Tomography | 1 | 2006 | 298 | 0.060 |
Why?
| | Healthcare Disparities | 1 | 2010 | 496 | 0.060 |
Why?
| | Analgesics, Opioid | 1 | 2011 | 793 | 0.060 |
Why?
| | Animals | 4 | 2023 | 33399 | 0.060 |
Why?
| | Computational Biology | 2 | 2019 | 588 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 693 | 0.060 |
Why?
| | Exercise | 1 | 2014 | 1657 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2010 | 781 | 0.060 |
Why?
| | Prevalence | 2 | 2019 | 2326 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 104 | 0.060 |
Why?
| | Trabecular Meshwork | 1 | 1983 | 75 | 0.050 |
Why?
| | Kinetics | 1 | 2006 | 1625 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 15 | 0.050 |
Why?
| | Glutathione | 1 | 1983 | 324 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2006 | 547 | 0.050 |
Why?
| | Appointments and Schedules | 1 | 2002 | 78 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1795 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2021 | 9 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 433 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 483 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2002 | 141 | 0.050 |
Why?
| | Clinical Protocols | 1 | 2002 | 238 | 0.050 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 24 | 0.050 |
Why?
| | Probability | 1 | 2020 | 305 | 0.040 |
Why?
| | Demography | 1 | 2020 | 274 | 0.040 |
Why?
| | Middle Aged | 4 | 2020 | 27627 | 0.040 |
Why?
| | Bias | 1 | 2020 | 198 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 5117 | 0.040 |
Why?
| | Genomics | 1 | 2024 | 705 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4709 | 0.040 |
Why?
| | Missouri | 1 | 1998 | 63 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4713 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2018 | 31 | 0.040 |
Why?
| | Computer Systems | 1 | 2018 | 47 | 0.040 |
Why?
| | Linear Models | 1 | 2019 | 827 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 1998 | 143 | 0.040 |
Why?
| | Students | 1 | 2021 | 509 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1868 | 0.030 |
Why?
| | Health Planning Guidelines | 1 | 2014 | 25 | 0.030 |
Why?
| | Calibration | 1 | 2014 | 135 | 0.030 |
Why?
| | Semantics | 1 | 2014 | 97 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1355 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2424 | 0.030 |
Why?
| | Names | 1 | 2013 | 12 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4596 | 0.030 |
Why?
| | Systems Integration | 1 | 2013 | 42 | 0.030 |
Why?
| | Airway Extubation | 1 | 2013 | 45 | 0.030 |
Why?
| | Research Personnel | 1 | 2014 | 158 | 0.030 |
Why?
| | Quality Control | 1 | 2013 | 159 | 0.030 |
Why?
| | CREB-Binding Protein | 1 | 2012 | 28 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2012 | 47 | 0.030 |
Why?
| | Medical Errors | 1 | 2013 | 89 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2014 | 586 | 0.030 |
Why?
| | Prospective Studies | 2 | 2014 | 6477 | 0.030 |
Why?
| | Pyrimidinones | 1 | 2012 | 86 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 749 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2513 | 0.020 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2012 | 165 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2013 | 422 | 0.020 |
Why?
| | Actins | 1 | 2012 | 404 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2013 | 545 | 0.020 |
Why?
| | Mice | 1 | 2023 | 15528 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2707 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9346 | 0.020 |
Why?
| | Body Mass Index | 1 | 2013 | 2092 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1440 | 0.020 |
Why?
| | Information Centers | 1 | 2005 | 4 | 0.020 |
Why?
| | Hospitals | 1 | 2010 | 601 | 0.020 |
Why?
| | Databases as Topic | 1 | 2005 | 73 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2275 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1200 | 0.020 |
Why?
| | Diamide | 1 | 1983 | 5 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 3590 | 0.010 |
Why?
| | Iodoacetates | 1 | 1983 | 4 | 0.010 |
Why?
| | Iodoacetamide | 1 | 1983 | 5 | 0.010 |
Why?
| | Ethylmaleimide | 1 | 1983 | 18 | 0.010 |
Why?
| | Carmustine | 1 | 1983 | 47 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 1983 | 11 | 0.010 |
Why?
| | Anterior Chamber | 1 | 1983 | 21 | 0.010 |
Why?
| | Free Radicals | 1 | 1983 | 104 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2446 | 0.010 |
Why?
| | Rabbits | 1 | 1983 | 780 | 0.010 |
Why?
| | Lens, Crystalline | 1 | 1983 | 126 | 0.010 |
Why?
| | Time | 1 | 2002 | 77 | 0.010 |
Why?
| | Hydrogen Peroxide | 1 | 1983 | 305 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19661 | 0.010 |
Why?
| | Cattle | 1 | 1983 | 979 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1983 | 940 | 0.010 |
Why?
| | Amino Acids | 1 | 1983 | 465 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 9003 | 0.010 |
Why?
| | Glucose | 1 | 1983 | 954 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2002 | 364 | 0.010 |
Why?
|
|
Kahn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|